Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BPI fold-containing family C protein (BPIFC) is a member of the BPI/LBP/PLUNC superfamily of lipid-binding serum glycoproteins, defined structurally by the presence of a conserved BPI fold, which consists of two domains forming a boomerang-shaped molecule with binding sites able to interact with hydrophobic ligands such as bacterial lipopolysaccharide. While closely related family members are established as components of host defense (such as bactericidal/permeability-increasing protein and PLUNC proteins), the specific biological function and disease relevance of BPIFC remain incompletely elucidated. There is no current evidence to support BPIFC as a direct therapeutic target, clinical biomarker, or molecule with established small-molecule interactions. It is primarily annotated as a protein-coding gene implicated by sequence similarity in lipid binding, potentially relevant to the innate immune response, but its role in human health or disease has yet to be clearly defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BPI fold-containing family C protein (BPIFC).